📖

GABRF Protein (GABA-A Receptor Subunit F)

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-gabrf-protein

Related Entities

Metadata

slug	proteins-gabrf-protein
entity_type	protein
kg_node_id	GABRFPROTEIN

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (30)

see_also📖Neurodegeneration60%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%

mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying protein aggregation cross50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%

related🔬RNA binding protein dysregulation across ALS FTD and AD50%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations40%

mentions🔬What are the mechanisms underlying protein aggregation cross40%

mentions🔬What are the mechanisms underlying rna binding protein dysre40%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%

related🧪Heat Shock Protein 70 Disaggregase Amplification40%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%

related🧪Serine/Arginine-Rich Protein Kinase Modulation40%